会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Transesterification of insoluble polysaccharides
    • 不溶性多糖的酯交换
    • US06228997B1
    • 2001-05-08
    • US09192209
    • 1998-07-10
    • Joseph A. AkkaraDavid L. KaplanFerdinando F. BrunoJonathan S. Dordick
    • Joseph A. AkkaraDavid L. KaplanFerdinando F. BrunoJonathan S. Dordick
    • C08B3708
    • C12P7/62C08B11/20C08B37/00C08B37/0012C08B37/003C12P19/04
    • Bacillus subtilis protease catalyzes the acylation of organic solvent-insoluble polysaccharides in isooctane solution containing vinyl esters of fatty acids as acyl donor. The reaction occurs only when the enzyme is solubilized via ion-pairing with the anionic surfactant dioctyl sulfosuccinate, sodium salt (AOT). Enzyme based acylation was demonstrated with amylose, cyclodextrins, cellulose, cellulose derivatives, and other polysaccharides such as chitosan, pullulan, and maltodextrose. These polysaccharides are reactive either as a cryogenically milled powder suspended in the organic solvent or as a thin film deposited onto ZnSe slides. For chitosan, &agr;-cyclodextrin, and hydroxyethyl cellulose (HEC), the enzymatic crosslinking reaction occurs using adipic acid divinyl ester (C6DVE). HEC forms a compound that gels in solvents such as ethyl alcohol and dimethyl sulfone oxide (DMSO). Electron spectroscopy chemical analysis (ESCA) of the first 100 Å of the amylose thin film amylose indicates that the acylated surface had a degree of substitution of 0.9±0.1 acyl chains per glucose moiety and this corresponded well to the expected regioselectivity of subtilisin catalysis on glucose-containing compounds. 1H-NMR studies indicated that only the C-6 hydroxyl groups of the glucose moiety were acylated with amylose and &ggr;-cyclodextrin. However, &bgr;-cyclodextrin, and &agr;-cyclodextrin were modified at secondary alcohols and at all three alcohols, respectively. This approach represents the first attempt at using enzymes to modify organic solvent-insoluble polymers in nonaqueous media.
    • 枯草芽孢杆菌蛋白酶催化有机溶剂不溶性多糖在含有作为酰基供体的脂肪酸乙烯基酯的异辛烷溶液中的酰化。 仅当酶通过离子配对与阴离子表面活性剂二辛基磺基琥珀酸钠(AOT)溶解时才发生反应。 用直链淀粉,环糊精,纤维素,纤维素衍生物和其它多糖例如壳聚糖,支链淀粉和麦芽糊精证明酶基酰化。 这些多糖作为悬浮在有机溶剂中的低温研磨粉末或沉积在ZnSe载片上的薄膜是反应性的。 对于壳聚糖,α-环糊精和羟乙基纤维素(HEC),使用己二酸二乙烯基酯(C 6 DVE)进行酶交联反应。 HEC形成在溶剂如乙醇和二甲基砜氧化物(DMSO)中凝胶化合物。 直链淀粉薄膜直链淀粉的第一个100的电子光谱化学分析(ESCA)表明,酰化表面的每个葡萄糖部分具有0.9±0.1个酰基链的取代度,这与枯草杆菌蛋白酶对葡萄糖的催化的预期区域选择性相当 的化合物。 1 H-NMR研究表明,只有葡萄糖部分的C-6羟基被直链淀粉和γ-环糊精酰化。 然而,β-环糊精和α-环糊精分别在仲醇和所有三种醇中进行了改性。 该方法代表了使用酶来修饰非水介质中有机溶剂不溶性聚合物的第一次尝试。
    • 38. 发明授权
    • Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
    • 用聚乙二醇作为抗粘连屏障和抗血栓形成材料的丝素蛋白基质的表面改性
    • US09427499B2
    • 2016-08-30
    • US13129738
    • 2009-11-17
    • Charu P. VepariDavid L. Kaplan
    • Charu P. VepariDavid L. Kaplan
    • A61L27/14A61L27/28A61L27/22A61L31/10A61L33/06A61L31/00
    • A61L31/005A61L31/10A61L33/068C08L71/02
    • The present invention provides compositions and methods for the production of silk fibroin matrices surface-PEGylated on one or more surfaces. Such surface-PEGylated silk fibroin matrices can be used in biomedical applications, such as anti-adhesive and anti-thrombosis materials. Silk matrices may be surface-PEGylated, for example, by a reaction with a functional group-activated PEG. Controlling the degree of PEGylation on surface of silk fibroin matrix can regulate both the degradation rate of the silk matrix, and the differentiated adhesion of cells or differentiated adsorption of proteins on the surface of the silk matrix. The present invention also provides for silk fibroin matrices having one or more surfaces possessing differentiated adhesion properties, which allows for tissue integration on the adherent side and inhibition of tissue adhesion to the opposing tissues or organs. Embedding active agents in silk fibroin matrices provides more benefits, such as promoting tissue ingrowth on the adherent side of the matrix.
    • 本发明提供了用于生产在一个或多个表面上表面聚乙二醇化的丝素蛋白基质的组合物和方法。 这种表面聚乙二醇化的丝素蛋白基质可用于生物医学应用,例如抗粘连和抗血栓形成的材料。 丝质基质可以被表面聚乙二醇化,例如通过与官能团活化的PEG的反应。 控制丝素蛋白基质表面聚乙二醇化程度可以调节蚕丝基质的降解速率,分化细胞粘附或蛋白质在丝质基质表面的分化吸附。 本发明还提供具有一个或多个具有分化的粘附性质的表面的丝素蛋白基质,其允许组合物在粘附层上的整合并抑制组织对相对组织或器官的粘附。 在丝素蛋白基质中包埋活性剂提供了更多的益处,例如促进组织向上生长在基质的粘着面上。
    • 40. 发明授权
    • All-protein implantable, resorbable reflectors
    • 全蛋白可植入,可吸收反射体
    • US09016875B2
    • 2015-04-28
    • US13386388
    • 2010-07-20
    • Fiorenzo OmenettoDavid L. Kaplan
    • Fiorenzo OmenettoDavid L. Kaplan
    • G02B5/124A61B5/00A61L27/22
    • A61B5/0059A61K49/0004A61L27/227
    • The invention provides for compositions and process for fabricating an optical reflector constructed from biocompatible and bioresorbable silk fibroin proteins. For example, the silk retroreflectors may be built based on millimeter size microprism arrays to rotate the image plane of imaged cortical layers, thus enhancing the amount of photons that are detectable in the reflected direction when inserted in a sample to be analyzed, and ultimately increasing in contrast ratio in multiphoton microscopy. Such device can be used as a label-free, biocompatible, bioresorbable, implantable device for various applications ranging from medical imaging/diagnostics, drug/therapeutic delivery, to food chain safety and environmental monitoring.
    • 本发明提供了用于制造由生物相容性和生物可再吸收的丝素蛋白构成的光反射体的组合物和方法。 例如,丝绸后向反射器可以基于毫米尺寸的微棱镜阵列构建,以旋转成像的皮质层的图像平面,从而增加当插入待分析的样品中时在反射方向上可检测的光子的量,并且最终增加 在多光子显微镜中的对比度。 这种装置可用作用于各种应用的无标签,生物相容性,生物可再吸收的可植入装置,从医学成像/诊断,药物/治疗递送,食品链安全和环境监测。